In a trial in 2-to-5-year-old children in Vietnam, the vaccine had more than 90 percent efficacy in the first year and protection lasted at least 4 years.
在越南二至五歲兒童的試驗中，疫苗在第一年有超過90％的效力，保護效果至少持續四年。